Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. Contrary to opioids, which bind to µ-opioid receptors in the central nervous procedure, conolidine modulates alternate molecular targets. A Science Developments examine observed that conolidine interacts With all the atypical chemokine receptor ACKR3/CXCR7, w